BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17654612)

  • 1. Hierarchical Bayes prioritization of marker associations from a genome-wide association scan for further investigation.
    Lewinger JP; Conti DV; Baurley JW; Triche TJ; Thomas DC
    Genet Epidemiol; 2007 Dec; 31(8):871-82. PubMed ID: 17654612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayes factors for genome-wide association studies: comparison with P-values.
    Wakefield J
    Genet Epidemiol; 2009 Jan; 33(1):79-86. PubMed ID: 18642345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of influential genetic markers among a large number of candidates based on effect estimation rather than hypothesis testing: an approach for genome-wide association studies.
    Strömberg U; Björk J; Broberg K; Mertens F; Vineis P
    Epidemiology; 2008 Mar; 19(2):302-8. PubMed ID: 18300718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal selection of markers for validation or replication from genome-wide association studies.
    Greenwood CM; Rangrej J; Sun L
    Genet Epidemiol; 2007 Jul; 31(5):396-407. PubMed ID: 17410553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empirical significance values for linkage analysis: trait simulation using posterior model distributions from MCMC oligogenic segregation analysis.
    Igo RP; Wijsman EM
    Genet Epidemiol; 2008 Feb; 32(2):119-31. PubMed ID: 17849492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative-risk regression models using cases and their parents.
    Schaid DJ
    Genet Epidemiol; 1995; 12(6):813-8. PubMed ID: 8788014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating covariates in mapping heterogeneous traits: a hierarchical model using empirical Bayes estimation.
    Biswas S; Lin S
    Genet Epidemiol; 2007 Nov; 31(7):684-96. PubMed ID: 17487892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy assessment of SNP sets for genome-wide disease association studies.
    Wollstein A; Herrmann A; Wittig M; Nothnagel M; Franke A; Nürnberg P; Schreiber S; Krawczak M; Hampe J
    Nucleic Acids Res; 2007; 35(17):e113. PubMed ID: 17726055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the utility of gene set methods in genomewide association studies of quantitative traits.
    Chasman DI
    Genet Epidemiol; 2008 Nov; 32(7):658-68. PubMed ID: 18481796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On multiple-testing correction in genome-wide association studies.
    Moskvina V; Schmidt KM
    Genet Epidemiol; 2008 Sep; 32(6):567-73. PubMed ID: 18425821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of genome-wide power of genetic association studies based on empirical data from the HapMap project.
    Nannya Y; Taura K; Kurokawa M; Chiba S; Ogawa S
    Hum Mol Genet; 2007 Oct; 16(20):2494-505. PubMed ID: 17666406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 100K genome-wide association scan for diabetes and related traits in the Framingham Heart Study: replication and integration with other genome-wide datasets.
    Florez JC; Manning AK; Dupuis J; McAteer J; Irenze K; Gianniny L; Mirel DB; Fox CS; Cupples LA; Meigs JB
    Diabetes; 2007 Dec; 56(12):3063-74. PubMed ID: 17848626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide scan for bovine twinning rate QTL using linkage disequilibrium.
    Kim ES; Berger PJ; Kirkpatrick BW
    Anim Genet; 2009 Jun; 40(3):300-7. PubMed ID: 19220232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian hierarchical modeling of drug stability data.
    Chen J; Zhong J; Nie L
    Stat Med; 2008 Jun; 27(13):2361-80. PubMed ID: 18338325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian variable and model selection methods for genetic association studies.
    Fridley BL
    Genet Epidemiol; 2009 Jan; 33(1):27-37. PubMed ID: 18618760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining association tests across multiple genetic markers in case-control studies.
    Zhou H; Wei LJ; Xu X; Xu X
    Hum Hered; 2008; 65(3):166-74. PubMed ID: 17940337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting and interpretation in genome-wide association studies.
    Wakefield J
    Int J Epidemiol; 2008 Jun; 37(3):641-53. PubMed ID: 18270206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bayesian predictive two-stage design for phase II clinical trials.
    Sambucini V
    Stat Med; 2008 Apr; 27(8):1199-224. PubMed ID: 17763528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of linkage disequilibrium between markers in linkage and association analyses.
    Dupuis J; Albers K; Allen-Brady K; Cho K; Elston RC; Kappen HJ; Tang H; Thomas A; Thomson G; Tsung E; Yang Q; Zhang W; Zhao K; Zheng G; Ziegler JT
    Genet Epidemiol; 2007; 31 Suppl 1():S139-48. PubMed ID: 18046770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal multistage designs--a general framework for efficient genome-wide association studies.
    Pahl R; Schäfer H; Müller HH
    Biostatistics; 2009 Apr; 10(2):297-309. PubMed ID: 19075295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.